Basic Information
| LncRNA/CircRNA Name | LINC00629 |
| Synonyms | LINC00629, LINC00629A, LINC00629B, LINC00629C, LINC00629D |
| Region | GRCh38_X:134549973-134559923 |
| Ensemble | ENSG00000227060 |
| Refseq | NR_038998 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | choriocarcinoma |
| ICD-0-3 | NA |
| Methods | qPCR, Cell transfection, Cell cycle assay etc. |
| Sample | placenta tissues, cell line (JEG-3) |
| Expression Pattern | down-regulated |
| Function Description | MIR503HG and LINC00629 were lower expressed in JEG-3 cell line than in normal placenta tissues. We found that the overexpression of both lincRNAs could inhibit migration and invasion in JEG-3 choriocarcinoma cell line. |
| Pubmed ID | 27023770 |
| Year | 2016 |
| Title | Placenta-Enriched LincRNAs MIR503HG and LINC00629 Decrease Migration and Invasion Potential of JEG-3 Cell Line. |
External Links
| Links for LINC00629 | GenBank HGNC NONCODE |
| Links for choriocarcinoma | OMIM COSMIC |